Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | CES1 | P23141 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 10/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALPL | P05186 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9958548 | 0.81 | PTGS2 (0.36) | PTGS2CA1CA2CA9 | |
| SCHEMBL3755699 | 0.80 | PKM (0.36) | CES2CES1CYP1A2ALPLTSHR | |
| SCHEMBL3742731 | 0.80 | CA1 (0.41) | CES2CES1CA1CA2CA9 | |
| SCHEMBL30585591 | 0.80 | CES2 (0.41) | CES2CES1CA1CA2CA9 | |
| SCHEMBL9958108 | 0.79 | PTGS2 (0.40) | PTGS2CYP1A2ALPLTSHRHSD17B10 | |
| SCHEMBL15763978 | 0.77 | CES2 (0.39) | CES2CES1CA1CA2CA9 | |
| SCHEMBL3748501 | 0.77 | KDM4E (0.38) | CES2CES1PTGS2CA1CA2 | |
| SCHEMBL8264078 | 0.75 | CES2 (0.38) | CES2CES1CA1CA2CA9 | |
| SCHEMBL9958085 | 0.75 | MEP1B (0.38) | PTGS2CYP1A2ALPLTSHRHSD17B10 | |
| SCHEMBL585314 | 0.74 | CA1 (0.56) | CA1CA2CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3306732-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2025-06-25 | — | — | EP | disclosed |
| CN-107534185-B | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2021-10-08 | — | — | CN | disclosed |
| EP-3343687-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME | MITSUI CHEMICALS INC (JP) | 2021-02-24 | — | — | EP | disclosed |
| US-20180241084-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERY AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2018-08-23 | — | — | US | disclosed |
| EP-3343687-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2018-07-04 | — | — | EP | disclosed |
| US-20180138551-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERY AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2018-05-17 | — | — | US | disclosed |
| EP-3306732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2018-04-11 | — | — | EP | disclosed |
| CN-107889541-A | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2018-04-06 | — | — | CN | disclosed |
| CN-107534185-A | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2018-01-02 | — | — | CN | disclosed |
| US-20170346127-A1 | LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2017-11-30 | — | — | US | disclosed |
| EP-3211706-A1 | LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2017-08-30 | — | — | EP | disclosed |
| CN-107078338-A | Lithium secondary battery | 三井化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-8512897-B2 | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES, LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| CN-101842349-B | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES | 2013-07-17 | — | — | CN | disclosed |
| US-20100291437-A1 | PHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION USING THE SAME, AND LITHIUM BATTERY | UBE INDUSTRIES, LTD. (JP) | 2010-11-18 | — | — | US | disclosed |
| CN-101842349-A | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES | 2010-09-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291437-A1 | PHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION USING THE SAME, AND LITHIUM BATTERY | SLC9B2, SLC13A5, KCNN2 | CES2 557/4885CES1 1941/4885PTGS2 4544/4885 |
| US-20170346127-A1 | LITHIUM SECONDARY BATTERY | SLC9B2, SCN11A, NUCB2 | CES2 727/4885CES1 3497/4885PTGS2 4374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.